Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 24 (4), 993-999, 2013-04
Elsevier BV